234 related articles for article (PubMed ID: 22806177)
41. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
[TBL] [Abstract][Full Text] [Related]
42. The predictive value of serum free light chain level early after allogeneic hematopoietic stem cell transplantation for chronic graft-versus-host disease, a preliminary study.
Wang B; Liang Z; Liu W; Sun Y; Cen X; Dong Y; Ren H
Clin Transplant; 2020 Jul; 34(7):e13865. PubMed ID: 32242991
[TBL] [Abstract][Full Text] [Related]
43. Assessment of the Salivary Concentrations of Selected Immunological Components in Adult Patients in the Late Period after Allogeneic Hematopoietic Stem Cell Transplantation-A Translational Study.
Brodzikowska A; Kochańska B; Bogusławska-Kapała A; Strużycka I; Górski B; Miskiewicz A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338734
[TBL] [Abstract][Full Text] [Related]
44. Oral Complications of Chronic Graft-Versus-Host Disease.
Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593
[TBL] [Abstract][Full Text] [Related]
45. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
[TBL] [Abstract][Full Text] [Related]
46. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
[TBL] [Abstract][Full Text] [Related]
47. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
48. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
[No Abstract] [Full Text] [Related]
49. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
[TBL] [Abstract][Full Text] [Related]
50. Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
Prenc E; Pulanic D; Pucic-Bakovic M; Ugrina I; Desnica L; Milosevic M; Pirsl F; Mitchell S; Rose J; Vrhovac R; Nemet D; Lauc G; Pavletic SZ
Front Immunol; 2021; 12():633214. PubMed ID: 34335560
[TBL] [Abstract][Full Text] [Related]
51. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
[TBL] [Abstract][Full Text] [Related]
53. Oral health-related quality of life of patients with oral chronic graft-versus-host disease.
Stolze J; Boor M; Hazenberg MD; Brand HS; Raber-Durlacher JE; Laheij AMGA
Support Care Cancer; 2021 Nov; 29(11):6353-6360. PubMed ID: 33884507
[TBL] [Abstract][Full Text] [Related]
54. Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease.
Ljubas Kelecic D; Lelas A; Karas I; Desnica L; Vukic T; Sabol I; Vranesic Bender D; Serventi Seiwerth R; Peric Z; Durakovic N; Vitali Cepo D; Vrhovac R; Nemet D; Pavletic S; Pulanic D; Krznaric Z
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2967-2978. PubMed ID: 32507973
[TBL] [Abstract][Full Text] [Related]
55. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
56. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
[TBL] [Abstract][Full Text] [Related]
57. Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease.
Bostanci N; Selevsek N; Wolski W; Grossmann J; Bao K; Wahlander A; Trachsel C; Schlapbach R; Öztürk VÖ; Afacan B; Emingil G; Belibasakis GN
Mol Cell Proteomics; 2018 Jul; 17(7):1392-1409. PubMed ID: 29610270
[TBL] [Abstract][Full Text] [Related]
58. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Zorn E; Kim HT; Lee SJ; Floyd BH; Litsa D; Arumugarajah S; Bellucci R; Alyea EP; Antin JH; Soiffer RJ; Ritz J
Blood; 2005 Oct; 106(8):2903-11. PubMed ID: 15972448
[TBL] [Abstract][Full Text] [Related]
59. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects.
Wu Y; Shu R; Luo LJ; Ge LH; Xie YF
J Periodontal Res; 2009 Oct; 44(5):636-44. PubMed ID: 19453860
[TBL] [Abstract][Full Text] [Related]
60. Biomarker Panel for Chronic Graft-Versus-Host Disease.
Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
